Pieris Pharmaceuticals Inc (PIRS)
11.70
-0.23
(-1.93%)
USD |
NASDAQ |
Apr 26, 16:00
11.70
0.00 (0.00%)
After-Hours: 20:00
Pieris Pharmaceuticals Profit Margin (Quarterly): -352.9% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -352.9% |
| September 30, 2023 | -55.08% |
| June 30, 2023 | 19.83% |
| March 31, 2023 | -680.9% |
| December 31, 2022 | -138.6% |
| September 30, 2022 | -181.3% |
| June 30, 2022 | -279.6% |
| March 31, 2022 | -46.42% |
| December 31, 2021 | -112.9% |
| September 30, 2021 | -407.6% |
| June 30, 2021 | -471.8% |
| March 31, 2021 | -26.69% |
| December 31, 2020 | -767.2% |
| September 30, 2020 | -486.0% |
| June 30, 2020 | -44.02% |
| March 31, 2020 | -27.12% |
| December 31, 2019 | -4.46% |
| Date | Value |
|---|---|
| September 30, 2019 | -17.13% |
| June 30, 2019 | -220.5% |
| March 31, 2019 | -121.1% |
| December 31, 2018 | -237.7% |
| September 30, 2018 | -73.73% |
| June 30, 2018 | -1.74% |
| March 31, 2018 | -209.9% |
| December 31, 2017 | 41.27% |
| September 30, 2017 | -179.8% |
| June 30, 2017 | -544.3% |
| March 31, 2017 | -595.2% |
| December 31, 2016 | -240.5% |
| September 30, 2016 | -789.3% |
| June 30, 2016 | -548.4% |
| March 31, 2016 | -333.8% |
| December 31, 2015 | -135.2% |
| September 30, 2015 | -963.7% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-767.2%
Minimum
Dec 2020
19.83%
Maximum
Jun 2023
-226.3%
Average
-138.6%
Median
Dec 2022
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -86.94% |
| Return on Assets | -33.77% |
| Return on Invested Capital | -86.94% |
| Operating Margin (Quarterly) | -422.0% |
| Return on Net Operating Assets | -147.3% |